Gissiprevenzione, 11,323 patients were enrolled in a clinical trial aimed at testing the effectiveness of n3 polyunsaturated fatty acids pufa and vitamin e. Gruppo italiano per lo studio della sopravvivenza nellinfarto miocardico prevenzione principal contacts. Sixmonth effects of early treatment with lisinopril and. Roberto latini istituto di ricerche farmacologiche mario negri. Thromboembolic event rate in paroxysmal and persistent. A highly significant reduction in mortality during hospitalization in streptokinasetreated patients was observed. Antiarrhythmic mechanisms of n3 pufa and the results of the. Predicting atrial fibrillation recurrence with circulating. Early protection against sudden death by n3 polyunsaturated fatty acids after myocardial infarction.
In gissi2 and its international study group extension, 20 891 patients with acute myocardial infarction who were admitted to coronary care units within 6 hours of symptom onset were enrolled in a randomized trial comparing the benefits and risks of streptokinase 1. The gruppo italiano per lo studio della sopravvivenza nellinfarto miocardico gissi is a. Gissiprevenzione investigators gruppo italiano per lo studio della sopravvivenza nellinfarto miocardico. Pragmatic and explanatory attitudes to randomized trials. In gissiprevenzione, patients were invited to follow mediterranean dietary habits, and were treated with uptodate preventive pharmacological interventions. Tavazzi l, tognoni g, franzosi mg, latini r, maggioni ap, marchioli r, nicolosi gl, porcu m. Since publication in the lancet, the original report has become a reference work for every paper which deals with thrombolysis. In gissiprevenzione, 11,323 patients were enrolled in a clinical trial aimed at testing the effectiveness of n3 polyunsaturated fatty acids pufa and vitamin e. Pdf cerebrovascular events after myocardial infarction.
Objectives to examine the roles of three systemic inflammatory markers in predicting recurrent af. Feruglio, md, antonio lotto, md, aldo selyini, md, gianni tognoni, md and gissi inyestigators milun, italy in the gissi trial, 11,712 patients with acute myocardial infarction were randomized to receive either standard care or standard care with 1. The gissi prevenzione groups1 primary endpoint was the combination of death and nonfatal myocardial infarction and stroke. Dietary supplementation with n3 polyunsaturated fatty acids and vitamin e after myocardial infarction. Whereas n3 fatty acids were shown to unambiguously improve overall survival, the results for vitamin e were not significant p007. Methods the association between the plasma concentrations of highsensitivity c reactive protein hscrp, interleukin6 il6 and pentraxin3 ptx3 with echocardiographic parameters and. In gissiprevenzione, patients were invited to follow mediterranean dietary habits, and were treated with uptodate preventive. Pdf gissiprevenzione trial roger harrison academia. Studio della streptochinasi nellinfarto miocardico gissi published the first report of a megatrial of a treatment. The gissihf trial included patients with new york heart association nyha class iiiv hf, without. Determinants of lateonset heart failure in myocardial. Designcase series derived from the gissi randomised trial. Gissihf rosuvastatine trial description and results.
Resultsg tognoni istituto di ricerche farmacologiche mario negri, milan, italyeuropean society of cardiology 2008 congressgissihf statin. Maggioni ap1, franzosi mg, fresco c, turazza f, tognoni g. Objectiveto examine the role of serum cholesterol in acute myocardial infarction in a population of patients with no history of coronary heart disease and to establish the nature of this association, the degree of risk, and the possible interaction between serum cholesterol and other major risk factors for acute myocardial infarction. Gissi prevenzione was an openlabelled trial, with no objective assessment of compliance such as measurement of n3 pufa and. Gissi a randomized trial with intravenous streptokinase in acute. Treatment with n3 polyunsaturated fatty acids after. Cardiovascular and other outcomes postintervention with. Gianni tognoni istituto di ricerche farmacologiche mario negri.
The design and method of the gissi trial have been described in detail previously i. Few data on the thromboembolic te risk of paroxysmal and persistent atrial. Patients5860 patients with acute myocardial infarction treated with 1. Chart showing randomized clinical trials on ace inhibitors from chf to coronary artery disease. Multicenter, open label, 2x2 factorial design, randomized trial. Effect of streptokinase on left ventricular modeling and. In the mid1980s, through widespread collaboration, the italian gruppo italiano per lo studio della streptochinasi nellinfarto miocardico gissi published the first report of a megatrial of a treatment. Briefly, gissi was a controlled unblinded trial with central randomization.
Associations of omega3 fatty acid supplement use with. The authors are solely responsible for the design and execution of the study, data analyses, drafting and editing of the paper and for its final contents. Between june, 1991, and july, 1993, 19,394 patients were randomised from 200 coronary care units in italy. In this report, we apply the qt variability approach to highfrequency ambulatory recordings from 268 individuals enrolled in the gruppo italiano per lo studio della sopravvivenza nellinsufficienza cardiacaheart failure gissihf trial. Rationale and design of the gissi heart failure trial. In the gissi trial, 11,712 patients with acute myocardial infarction were randomized to receive either standard care or standard care with 1. Setting176 coronary care units in italy giving various levels of care. Gruppo italiano per lo studio della sopravvivenza nellinfarto miocardio gissiprevenzione was conceived as a population, pragmatic trial on patients with recent myocardial infarctions conducted in the framework of the italian public health system. The gissiprevenzione study was a clinical trial designed to test the benefits of vitamin e 300 mg daily and n3 polyunsaturated fatty acid supplementation 1 g daily among patients surviving. We undertook a randomised, doubleblind, placebocontrolled trial in 326. Funding for the gissiaf trial was provided by novartis, which had no role in the trial design, study execution, data collection, analysis, data interpretation, or writing of the report. Background inflammation may play a significant role in the pathogenesis of atrial fibrillation af. Primary outcomesaend point rosuvastatin 10 mg n2285, placebo adjusted hazard ratio % n2289, % 95% cimortality 29. Omega3 fatty acids had neutral effects on cardiovascular outcomes.
The package of treatments recommended after extensive discussion with all the investigators betablocker, aspirin, nitrates was widely adopted. References 1 marchioli r, barzi f, bomba e, et al, on behalf of the gissiprevenzione investigators. The original publication of the gissiprevenzione 2 reported that when 11 323 patients surviving a very recent myocardial infarction mi were randomized to 1. Maria grazia franzosi istituto di ricerche farmacologiche mario negri. Gissi3 is a multicentre randomised clinical trial to assess the efficacy of lisinopril, transdermal glyceryl trinitrate gtn, and their combination in improving survival and ventricular function after acute myocardial infarction ami. This article is from bmc cardiovascular disorders, volume. Gin3 trial i does not simply represent an account of the mediumterm consequences of a randomized treatment started in the very ear. The results of the gissiprevenzione trial in the general framework of secondary prevention, european heart journal, volume 21, issue 12, 1 june 2000, pages 949952.
Gissiprevenzione was an openlabelled trial, with no objective assessment of compliance such as measurement of n3 pufa and. Thrombolytic trials, with their short and longterm followup, have since. The gruppo italiano per lo studio della sopravvivenza nellinfarto miocardico gissi italian group for the study of the survival of myocardial infarction is a cardiology research group founded as a collaboration between two italian organisations the mario negri institute and the associazione nazionale dei medici cardiologi ospedalieri anmco. The gissiprevenzione groups1 primary endpoint was the combination of death and nonfatal myocardial infarction and stroke. The results of the gissi trial confirm early epidemiological reports on the protective effect of a diet rich in fish n3 pufa are considered the main active component, and the findings of other much smaller controlled trials, not sufficiently powered to measure the impact of. Gissiprevenzione was conceived as a population, pragmatic trial on patients with recent myocardial infarction conducted in the framework of the italian public health system. Of the 11 712 originally randomized patients in the gissi1 study. On the reanalysis of the gissiprevenzione circulation.
We, however, disagree with the investigators pessimistic interpretation of the datathat vitamin e had no benefit. F barzi 1,2, m woodward 2, rm marfisi 1, l tavazzi 3, g tognoni 1, f valagussa 4, and r marchioli 1 on behalf of gissiprevenzione investigators. Tenyear followup of the first megatrial testing thrombolytic. Expert pdf editor x64 for windows xp,vista,7,8 64bit and later.
During the 18 months of the study, italy was covered. Qt variability index on 24hour holter independently. This, confirmed the beneficial effects of thrombolysis after heart attack. Objective the outcome reduction with initial glargine intervention origin trial reported neutral effects of insulin glargine on cardiovascular outcomes and cancers and reduced incident diabetes in highcardiovascular risk adults with dysglycemia after 6. Description and results of gissihf rosuvastatine nct00336336 randomized clinical trial comparing lowdose rosuvastatin 10 mg daily vs placebo in patients with nyha classes ii to iv heart failure, whatever the cause and the lvef and already receiving optimized recommended therapy with no clear indication or contraindication to cholesterollowering therapy. The results of the gissi trial confirm early epidemiological reports on the protective effect of a diet rich in fish n3 pufa are considered the main active component, and the findings of other much smaller controlled trials, not sufficiently powered to measure the impact of the treatment on cardiovascular and overall mortality. Patients were invited to follow mediterranean dietary habits, and were treated with uptodate preventive pharmacological interventions. The reanalysis 1 of the results of the gissiprevenzione secondary prevention trial appearing in this issue of circulation greatly increases the importance of this large, wellconducted clinical trial. The first gruppo italiano per lo studio della streptochinasi nellinfarto gissi study showed striking evidence of the effectiveness and safety of intravenous thrombolytic treatment in acute myocardial infarction mi. Typical chest pain accompanied by st changes, either. Cerebrovascular events after myocardial infarction. Effect of n3 polyunsaturated fatty acids in patients with chronic heart. Objectivesto describe the epidemiology of cerebrovascular events in patients given or not given fibrinolytic treatment and to assess the prognostic implications and risk factors. Gruppo italiano per lo studio della streptochinasi nellinfarto miocardico gissi.
Archived expert pdf editor x32 expert pdf editor x86 v4 for windows xp,vista,7,8 32bit and later. The gissiprevenzione trial involved 11 323 lowrisk patients nyha class. According to the study protocol 4 the 6month followup was planned to. Aldo maggioni istituto di ricerche farmacologiche mario negri. Patients were considered eligible for the trial if 1 they had chest pain accompanied by st segment elevation or depres sion 2 1 mm in any limb lead of the electrocardiogram ecg. Objective to evaluate if and to what extent pharmacological treatments aimed at different and probably complementary risk factors for atherosclerosis andor thrombosis improve the profile in terms of survival, morbidity, quality of health of patients surviving beyond the hospital phase of acute myocardial infarction. Gruppo italiano per lo studio della streptochinasi nellinfarto miocardico gissi 1986. Largescale trials of thrombolytic therapy for acute. The results of the gissiprevenzione trial in the general framework of secondary prevention.
351 834 635 664 1493 1247 612 432 1072 1135 181 1165 981 126 968 272 209 343 1304 1125 1201 421 60 413 1474 57 104 695 662 141 767 609 1031 452